Speaker:

Good morning, Dr.

Speaker:

Seyfried.

Speaker:

It's a true pleasure to

Speaker:

have you on the podcast today.

Speaker:

Obviously, we'll be discussing all things

Speaker:

cancer in short order.

Speaker:

But before we get into it, would you mind

Speaker:

introducing yourself to the audience for

Speaker:

those who aren't familiar

Speaker:

with you and your body of work?

Speaker:

Yeah, well, well, thank you, Rob.

Speaker:

It's nice to be here.

Speaker:

I'm a professor of

Speaker:

biology at Boston College.

Speaker:

I have been here for,

Speaker:

well, since 1985, 40 years now.

Speaker:

And before that, I was at Yale University

Speaker:

in New Haven, Connecticut.

Speaker:

Here at Boston College, I've taught a

Speaker:

broad range of classes over the years,

Speaker:

neurobiology,

Speaker:

neurochemistry, neurogenetics.

Speaker:

Now I teach general biology to the

Speaker:

non-majors, as well as an advanced class

Speaker:

in cancer metabolism.

Speaker:

Cancer is a metabolic disease.

Speaker:

So our background for

Speaker:

biochemistry was lipid biochemistry.

Speaker:

I did a lot of work

Speaker:

on lipid biochemistry.

Speaker:

And as far as diseases are concerned,

Speaker:

lipid storage diseases, as well as

Speaker:

genetic diseases, epilepsy in particular.

Speaker:

And now our main focus over the last

Speaker:

quarter of a century has been

Speaker:

predominantly cancer.

Speaker:

But we are moving into also

Speaker:

other chronic diseases as well.

Speaker:

So I have a kind of a

Speaker:

broad-based experience.

Speaker:

I have a degree in genetics and

Speaker:

biochemistry, a

Speaker:

master's degree in genetics.

Speaker:

So those are the background educational

Speaker:

experience that I've had.

Speaker:

That's incredible.

Speaker:

And a reason, I

Speaker:

suppose, I could only dream of.

Speaker:

I think one of the big issues in the

Speaker:

health podcast space is creating content

Speaker:

that is sort of based on actual science

Speaker:

and to have someone with your background

Speaker:

and credibility, I feel just, well, at

Speaker:

least hopefully sort of highlight that

Speaker:

we're not here just to obviously discuss

Speaker:

pseudoscience today, that this is all

Speaker:

sort of based in empirical data.

Speaker:

Dr.

Speaker:

Seafree, I know we're here to really talk

Speaker:

about the metabolic theory of cancer, but

Speaker:

I think it would be prudent to maybe

Speaker:

start off with having a quick

Speaker:

conversation about

Speaker:

what cancer actually is.

Speaker:

And I know it's likely a dull question,

Speaker:

but I do feel it's that very few people

Speaker:

actually know what the disease is.

Speaker:

It's just something that

Speaker:

they aim to just not get.

Speaker:

I've got a few questions there, but yeah,

Speaker:

maybe we could just start off with that.

Speaker:

Cancer Biology 101, as it were, if you

Speaker:

would just mind running

Speaker:

through what cancer is.

Speaker:

Well, it's actually a very, it's a

Speaker:

complicated problem, but it's a very

Speaker:

simple definition of what cancer is.

Speaker:

It's cell division out of control,

Speaker:

dysregulated cell growth.

Speaker:

So people say, well, what's cancer?

Speaker:

It's just a bunch of cells that are no

Speaker:

longer regulated in their growth.

Speaker:

Of course, the origin of

Speaker:

that phenomenon is broad.

Speaker:

But what is it that makes a population of

Speaker:

cells in a particular organ of someone's

Speaker:

body to start growing in a dysregulated

Speaker:

way as opposed to normal cell division,

Speaker:

which is regulated?

Speaker:

In parts of our body,

Speaker:

there's wear and tear.

Speaker:

Cells naturally die and are replaced.

Speaker:

But the replacement of dead cells is a

Speaker:

very organized process.

Speaker:

They grow, they divide, and they, however

Speaker:

many divisions is necessary to replace

Speaker:

those that are missing, is a

Speaker:

well-regulated process.

Speaker:

And we know now that's all

Speaker:

controlled by the mitochondria.

Speaker:

But an example of cell

Speaker:

division under control,

Speaker:

one of the, is in the gut, you have the

Speaker:

crypt cells that seem to always replace

Speaker:

other cells in a very regulated way.

Speaker:

And in the liver, you

Speaker:

have liver regeneration.

Speaker:

Liver is an interesting organ because if

Speaker:

you remove a lobe of the liver, the liver

Speaker:

will regenerate the

Speaker:

missing part of the lobe.

Speaker:

And the speed of liver regenerating cells

Speaker:

is just as fast as that

Speaker:

of the fastest cancer.

Speaker:

The only difference is that the liver

Speaker:

regeneration is regulated growth, whereas

Speaker:

the hepatoma of the liver, which is liver

Speaker:

cancer, is dysregulated growth.

Speaker:

And the biochemistry of those two

Speaker:

populations is strikingly different.

Speaker:

So when you ask what is cancer, it's

Speaker:

dysregulated growth in a population of

Speaker:

cells in someone's organ, which differs

Speaker:

from regulated growth

Speaker:

of cells in that organ.

Speaker:

So sort of after control mitosis, you

Speaker:

might say, in a nutshell.

Speaker:

Yeah.

Speaker:

And the question that has perplexed the

Speaker:

field for decades is what regulates, what

Speaker:

is responsible for

Speaker:

regulated growth in the first place?

Speaker:

Why would one cell know when to stop

Speaker:

growing and another cell

Speaker:

not know when to stop growing?

Speaker:

And that all comes back to the role of

Speaker:

the mitochondria and the cytoplasm.

Speaker:

The mitochondrion controls calcium

Speaker:

signaling within the cell.

Speaker:

Nobel prizes have been awarded for people

Speaker:

to learn the cyclins and

Speaker:

going through the cell cycle.

Speaker:

And that cell cycle is all controlled by

Speaker:

calcium signaling from the mitochondria.

Speaker:

So when mitochondria of the cell become

Speaker:

dysfunctional in the sense of producing

Speaker:

energy and that calcium gradients, they

Speaker:

fall back on a fermentation metabolism,

Speaker:

which is an ancient form

Speaker:

of energy without oxygen.

Speaker:

And the mitochondrion loses control of

Speaker:

the differentiated state.

Speaker:

That being anaerobic respiration.

Speaker:

Yeah, anaerobic.

Speaker:

You can grow cancer cells in the absence

Speaker:

of oxygen or in the presence

Speaker:

of cyanide and they survive.

Speaker:

So which would

Speaker:

normally kill normal cells.

Speaker:

And that's because their energy

Speaker:

metabolism is of an ancient type.

Speaker:

It's the type of energy that existed on

Speaker:

the planet before oxygen came into the

Speaker:

atmosphere two and a

Speaker:

half billion years ago.

Speaker:

It was a fermentation metabolism,

Speaker:

generating energy without oxygen.

Speaker:

And the default state of

Speaker:

cells is proliferation.

Speaker:

The default energy state

Speaker:

of cells is fermentation.

Speaker:

So when what cancer cells are doing is

Speaker:

they're simply falling back on their

Speaker:

default proliferative state and their

Speaker:

default energy state behaving, behaving

Speaker:

much as they were of all cells that

Speaker:

existed before oxygen, which was

Speaker:

unbridled proliferation.

Speaker:

And they would die as soon as the fuels

Speaker:

that drove the flow drove the

Speaker:

fermentation metabolism would dissipate

Speaker:

in the micro environment

Speaker:

and the cells would die.

Speaker:

So it was purely an energy

Speaker:

driven process without regulation.

Speaker:

During the origin of life on the planet,

Speaker:

archaeobacteria fused with other other

Speaker:

cells to develop the mitochondria.

Speaker:

And it was the mitochondria that allowed

Speaker:

the division of energetic labor in the

Speaker:

cells, allowing metazones to form and the

Speaker:

most complex multicellular organisms that

Speaker:

we have today all all due to the energy

Speaker:

capacity of the mitochondria.

Speaker:

And the nucleus, which everybody seems to

Speaker:

have focused on, is because you could see

Speaker:

it sometimes even with the naked eye,

Speaker:

whereas the mitochondria for centuries

Speaker:

could not be seen clearly until you had

Speaker:

the electron microscope and more

Speaker:

sophisticated ways of

Speaker:

looking at this organelle.

Speaker:

But in a nutshell, it's the mitochondria

Speaker:

that controls the

Speaker:

regulation of genes in the nucleus.

Speaker:

So all the epigenetic stuff you hear

Speaker:

about is mostly mitochondrial controlled

Speaker:

mitochondria controlled.

Speaker:

So the nucleus is kind of an obedient

Speaker:

slave of whatever the mitochondria does

Speaker:

because of that

Speaker:

organelle becomes corrupted.

Speaker:

The cell falls back as a and one of these

Speaker:

dysregulated growths.

Speaker:

So everything comes back to the origin of

Speaker:

cancer as a corruption of mitochondrial

Speaker:

function only in cells that can switch to

Speaker:

the ancient fermentation pathways, which

Speaker:

can explain why certain cells

Speaker:

in our body never become tumor.

Speaker:

Red blood cells can't become a tumor

Speaker:

because they have no mitochondria or

Speaker:

nucleus in the first place.

Speaker:

Neurons of our brain

Speaker:

cannot sustain fermentation.

Speaker:

So you rarely, if ever,

Speaker:

get cancers from neurons.

Speaker:

They get from real cells.

Speaker:

What about cardiac tissue?

Speaker:

Cardiac tissue rarely, if ever, gets

Speaker:

cancer because they cannot replace

Speaker:

oxidative phosphorylation with substrate

Speaker:

level phosphorylation.

Speaker:

So you rarely, if ever, get cancer of

Speaker:

muscle, a striate or cardiac tissue

Speaker:

because they die and you can't get a

Speaker:

cancer cell from a dead cell.

Speaker:

So we're able to go through the body and

Speaker:

look at the kinds of tissues that form

Speaker:

cancer because they have the capacity to

Speaker:

transition from oxidative phosphorylation

Speaker:

to substrate level phosphorylation, which

Speaker:

is a protracted event that

Speaker:

doesn't happen overnight.

Speaker:

You really have to abuse the hell out of

Speaker:

your mitochondria in a

Speaker:

chronic way to get cancer.

Speaker:

Cancer is very hard to get.

Speaker:

I know it's exploding as an epidemic, but

Speaker:

we abuse the crap out of our bodies and

Speaker:

that's why we're getting so much cancer.

Speaker:

But it's really hard to get cancer.

Speaker:

So when you say, well, how come so many

Speaker:

people because they because their bodies

Speaker:

have been chronically abused by a variety

Speaker:

of insults, many of which

Speaker:

they're not even aware of.

Speaker:

But that's that's how you get cancer.

Speaker:

It's a chronic disruption of oxidative

Speaker:

phosphorylation coupled to a compensatory

Speaker:

substrate level phosphorylation.

Speaker:

And Warburg knew this a long time ago

Speaker:

from the 1920s, but he only knew that it

Speaker:

was a glucose driven transition from.

Speaker:

But we now discovered and have I had the

Speaker:

concept but not the evidence.

Speaker:

But now we published the big paper

Speaker:

recently that the cancer cell can ferment

Speaker:

an amino acid called glutamine.

Speaker:

So you get sugar and amino acid

Speaker:

fermentation are driving the dysregulated

Speaker:

growth of the tumor cell.

Speaker:

And the field all thought it was

Speaker:

glutamine respiration oxidative but it's

Speaker:

not its glutamine fermentation within the

Speaker:

mitochondria itself.

Speaker:

So the very organelle that's supposed to

Speaker:

get energy through oxidative

Speaker:

phosphorylation is also producing energy

Speaker:

through substrate level phosphorylation,

Speaker:

which is a fermentation mechanism.

Speaker:

This is what's blowing

Speaker:

the doors off the field.

Speaker:

You know, they never realized that the

Speaker:

very organelle could also ferment.

Speaker:

And that goes back to its organ its its

Speaker:

origin as a bacteria itself.

Speaker:

So, you know, once once you understand

Speaker:

evolutionary biology, all the pieces of

Speaker:

cancer fall into place

Speaker:

quite, quite reasonably.

Speaker:

Now, it really does.

Speaker:

And I just love the fact you do brought

Speaker:

up the mitochondria as being more than

Speaker:

just this sort of this

Speaker:

energy factory or the body.

Speaker:

It's just involved in so many genetic

Speaker:

processes beyond just

Speaker:

helping to create ATP.

Speaker:

And yeah, thanks for that.

Speaker:

It really does sort of provide some

Speaker:

context to what is going for

Speaker:

the rest of the conversation.

Speaker:

I reckon the natural follow up then

Speaker:

again, this is quite a

Speaker:

loose question, I suppose.

Speaker:

I suppose.

Speaker:

And you've really answered this too,

Speaker:

to an degree.

Speaker:

But I'd sort of and beyond the sort of

Speaker:

the metabolic side of it, I'd love to

Speaker:

sort of get your your thoughts on the

Speaker:

different theories that

Speaker:

are sort of driving cancer.

Speaker:

Obviously, it's a complex,

Speaker:

this complex aetiology there.

Speaker:

And it's it would be and it shouldn't be

Speaker:

viewed from this sort of reductionist

Speaker:

viewpoint that there is just one

Speaker:

mechanism that causes cancer.

Speaker:

I know in my brief experience in academia

Speaker:

that people studying these conditions can

Speaker:

often get wrapped up in their own

Speaker:

mechanisms and

Speaker:

occasionally be blinded by research.

Speaker:

Obviously, you have a

Speaker:

fairly well-rounded view.

Speaker:

So would you mind talking us through the

Speaker:

various sort of and I hope sort of

Speaker:

phrases correctly proposed triggers,

Speaker:

maybe or underlying mechanisms that sort

Speaker:

of lead to the development of this

Speaker:

condition, sort of the genetic causes,

Speaker:

the environmental risk factors, the

Speaker:

immunological side of things?

Speaker:

I don't know if I phrased that correctly,

Speaker:

or if that makes sense.

Speaker:

Yeah, well, it does.

Speaker:

I mean, when you look at the history of

Speaker:

of the disorder that has intrigued

Speaker:

scientists, you know, for centuries,

Speaker:

you know, we knew about cancer a long

Speaker:

time ago, VirCal, and the 1800s people

Speaker:

were studying these things.

Speaker:

You know, and how does it start?

Speaker:

You know, you have the emergence of

Speaker:

different ideas, concepts of

Speaker:

what cancer, what cancer is.

Speaker:

The current view taken by all major

Speaker:

research centers and academic centers is

Speaker:

that it's a genetic disease.

Speaker:

I know the UK thinks that the United

Speaker:

States government, National Cancer

Speaker:

Institute, believe that.

Speaker:

I think most of the cancer institutes

Speaker:

around the world, the French, the

Speaker:

Germans, the English, all Western major,

Speaker:

and even in China and Japan and Korea,

Speaker:

you know, South America,

Speaker:

they're all of the view

Speaker:

that cancer is a genetic.

Speaker:

It seems to be some sort of a paralytic

Speaker:

mindset throughout the world.

Speaker:

It's an indoctrination of brainwashing,

Speaker:

if you will, of what this

Speaker:

disease is supposed to be.

Speaker:

But it wasn't always that way.

Speaker:

You know, there was the viral cancer was

Speaker:

a virus caused by viruses.

Speaker:

Cancer was a metabolic disease.

Speaker:

You know, cancer is a genetic disease.

Speaker:

So you have to put all the views over

Speaker:

time into what it is.

Speaker:

And, you know, Warburg started the idea

Speaker:

that it was a

Speaker:

mitochondrial metabolic disease.

Speaker:

But he couldn't explain certain things

Speaker:

which we now can't explain.

Speaker:

He didn't know about the glutamine issue,

Speaker:

nor did he realize that a lot of the

Speaker:

oxygen that cancer cells consume is not

Speaker:

used for ATP but produces reactive oxygen

Speaker:

species, ROS, which are radicals.

Speaker:

And they cause, in large part, the

Speaker:

mutations in the nucleus.

Speaker:

So, you know, certain viruses, okay,

Speaker:

well, we knew certain like papilloma

Speaker:

viruses and hepatitis

Speaker:

viruses and the Rous sarcoma virus.

Speaker:

Peyton Rous was a Nobel Prize receiver

Speaker:

for his virus particle.

Speaker:

We now put all that together.

Speaker:

We know all these viruses damage

Speaker:

oxidative phosphorylation, chronically

Speaker:

causing this transition to

Speaker:

substrate-level phosphorylation.

Speaker:

But it was the Watson and Crick DNA

Speaker:

structural analysis that kind of sent the

Speaker:

whole field off into the abyss,

Speaker:

chasing stuff that we are still chasing.

Speaker:

Because it became exciting to bring a

Speaker:

very complicated mishi-marshi disease

Speaker:

back into a molecular configuration.

Speaker:

And I think that was,

Speaker:

I call it physics envy.

Speaker:

Biology had always been a poor stepchild

Speaker:

to the pure, rational thought of the

Speaker:

human mind, which was physics.

Speaker:

And when the DNA structure was defined,

Speaker:

and you could explain the arrangement of

Speaker:

amino acids and RNAs all linked back to

Speaker:

the structure of the DNA, biology was

Speaker:

brought from an observational

Speaker:

observational kind of a disorder or a

Speaker:

field into a more quantitative way.

Speaker:

And then, of course, as soon as you

Speaker:

started looking at cancer cells, you

Speaker:

start to see chromosomal abnormalities.

Speaker:

That goes back to Theodore Bovary, who

Speaker:

knew nothing about cancer.

Speaker:

And he said, "I think cancer might be

Speaker:

something to do with chromosomes."

Speaker:

Purely speculative.

Speaker:

He even said, "I'm probably wrong about

Speaker:

everything," and he was.

Speaker:

But the field grabbed ahold of him as the

Speaker:

father of the genetic theory of cancer.

Speaker:

And then, of course, you started to see

Speaker:

gene mutations

Speaker:

associated with certain cancers.

Speaker:

And then we spent billions of dollars on

Speaker:

the cancer genome projects, looking at

Speaker:

every kind of a mutation.

Speaker:

And then therapies, precision in medicine

Speaker:

and all this developed around the genomic

Speaker:

view of cancer, where we're going to have

Speaker:

precision medicines,

Speaker:

targeted therapies, and all this kind of

Speaker:

stuff, which is where we are today.

Speaker:

And all the governments and academic

Speaker:

institutions are giving away millions of

Speaker:

dollars in grants to people trying to

Speaker:

hunt down genes that could be responsible

Speaker:

for the dysregulated cell growth.

Speaker:

So it comes back.

Speaker:

We know cancer is a

Speaker:

dysregulated cell growth.

Speaker:

What's causing that?

Speaker:

Well, according to the somatic mutation

Speaker:

theory, which is the dominant theory

Speaker:

today, it's mutations

Speaker:

that are causing that.

Speaker:

But I've clearly shown that those

Speaker:

mutations are largely irrelevant.

Speaker:

With our research, they can't attack it

Speaker:

because the evidence is too strong.

Speaker:

So when you have evidence that's

Speaker:

overwhelmingly strong and it's not

Speaker:

consistent with your general

Speaker:

theory, then you ignore it.

Speaker:

But you're only going

Speaker:

to ignore it for so long.

Speaker:

So when you develop a theory,

Speaker:

theories are supported by a massive

Speaker:

amounts of evidence.

Speaker:

The somatic mutation theory was very,

Speaker:

very strong because you found almost all

Speaker:

cancers with somatic mutations.

Speaker:

And these somatic mutations, some of them

Speaker:

were linked to the cell cycle, which you

Speaker:

could then link a mutation in the genome

Speaker:

to something that would lead to

Speaker:

dysregulation or

Speaker:

dysfunction of the cell cycle.

Speaker:

And that made a lot of sense.

Speaker:

So people grabbed onto that.

Speaker:

And because it was so molecular and so

Speaker:

quantitative and approachable by really

Speaker:

sophisticated technologies which have

Speaker:

developed around cancer, like all these

Speaker:

sequencing, unbelievable AI now,

Speaker:

artificial intelligence helping analysis

Speaker:

of sequencing, and all of the different

Speaker:

kinds and types of mutations that were

Speaker:

found in cancer cells.

Speaker:

I mean, it was an explosion of molecular

Speaker:

biology associated with cancer.

Speaker:

So that was very

Speaker:

attractive to a lot of people.

Speaker:

But then having done work in Meyerle lab

Speaker:

and seeing research that was far more

Speaker:

consistent with what Otto Wirberg said

Speaker:

than with the somatic mutation theory, I

Speaker:

began to look at this.

Speaker:

But getting back to theories, I like to

Speaker:

compare what's happening today with the

Speaker:

mitochondrial metabolic theory replacing

Speaker:

the somatic mutation theory because it really takes a lot of

Speaker:

evidence to replace a theory.

Speaker:

Einstein's theory of relativity could

Speaker:

still be replaced, but has not yet been.

Speaker:

And there are physicists that are

Speaker:

constantly trying to show where Einstein

Speaker:

was wrong, and they believe

Speaker:

they might, but they haven't.

Speaker:

Darwin's theory of evolution has been

Speaker:

challenged many times, but it has not

Speaker:

been overthrown because the data that

Speaker:

support it are stronger than the data that don't support it.

Speaker:

And then you have the geocentric

Speaker:

heliocentric theory of the solar system,

Speaker:

where for 1800 years, people thought that

Speaker:

the Earth was the

Speaker:

center of the solar system.

Speaker:

And we developed equants, deference, and

Speaker:

epicycles to try to predict

Speaker:

the positions of the planets.

Speaker:

And Copernicus just

Speaker:

replaced the Earth with the sun.

Speaker:

And all of a sudden, a lot of stuff was

Speaker:

far less complicated and more understandable.

Speaker:

So the heliocentric theory replaced the

Speaker:

geocentric theory, opened up a scientific

Speaker:

revolution during the Middle Ages,

Speaker:

the Renaissance period.

Speaker:

What we're having today is that

Speaker:

mitochondrial metabolic theory is

Speaker:

overturning the somatic mutation theory.

Speaker:

And the consequences are going to be

Speaker:

every bit as phenomenal as what happened

Speaker:

during the Copernican revolution.

Speaker:

So we look at

Speaker:

evidence to support a theory.

Speaker:

If cancer is a disease of somatic

Speaker:

mutations, which is the current dogma,

Speaker:

irrefutable truth, the silent assumption,

Speaker:

cancer is a genetic disease.

Speaker:

Well, now with deep sequencing and deeper

Speaker:

analysis, we find some cancer cells that

Speaker:

don't have any mutations, yet they're

Speaker:

growing out of control.

Speaker:

So when I looked at those, there's not many papers that I've looked at.

Speaker:

So when I looked at those, there's not

Speaker:

many papers, but there are

Speaker:

some very clear findings.

Speaker:

And then when I say, what do the

Speaker:

investigators who believe that cancer is

Speaker:

a genetic disease say about cancer cells

Speaker:

that don't have mutations or

Speaker:

they can't find any mutations?

Speaker:

And they don't say anything.

Speaker:

So when I went back and looked at their

Speaker:

explanation, they

Speaker:

didn't even, they ignored it.

Speaker:

They didn't even talk about the cancer

Speaker:

cells that had no mutations.

Speaker:

They just seemed to focus on all the

Speaker:

cancer cells that had mutations.

Speaker:

And I said, you got a glaring

Speaker:

inconsistency in your theory, staring you

Speaker:

in the face and you did not address it.

Speaker:

What the hell is going on with that?

Speaker:

Then, of course, they realized that

Speaker:

there's so many hundreds of thousands of

Speaker:

mutations in some of these tumor cells.

Speaker:

They all can't be drivers

Speaker:

of dysregulated cell growth.

Speaker:

So then the field decided to reclassify

Speaker:

some of the mutations as

Speaker:

passenger genes and driver genes.

Speaker:

So we then moved into the driver gene

Speaker:

mentality, which lasted several decades.

Speaker:

Where only some of these many mutations

Speaker:

are truly responsible for dysregulated

Speaker:

cell growth and we

Speaker:

redefined them as called drivers.

Speaker:

And that got, that generated a lot of

Speaker:

excitement since the 19, early 1980s, I

Speaker:

guess, middle eighties, driver genes,

Speaker:

driver, oh, the driver genes.

Speaker:

So now with deep sequencing and more

Speaker:

sophisticated technologies, we're finding

Speaker:

all kinds of mutations in

Speaker:

driver genes in our normal tissues.

Speaker:

Like you and me.

Speaker:

I mean, we got all kinds of mutations in

Speaker:

P53 and MIC and RAS and all these kinds

Speaker:

of genes that are in our normal tissues

Speaker:

and are not dysregulated in growth.

Speaker:

How do you explain that?

Speaker:

That's inconsistent with

Speaker:

your somatic mutation theory.

Speaker:

Are there any real sort of polygenic risk

Speaker:

goals maybe that sort of have been

Speaker:

identified in respect to this?

Speaker:

Well, the nuclear mitochondrial transfer

Speaker:

experiments throw, that's the real nail

Speaker:

in the coffin for the whole thing.

Speaker:

Because what was done on a variety of

Speaker:

different types of cancers is that the

Speaker:

nucleus of the tumor cell is now placed

Speaker:

in the cytoplasm of a

Speaker:

non-neoplastic cell.

Speaker:

And invariably you get regulated growth,

Speaker:

despite the continued presence of

Speaker:

whatever kind of genetic abnormality

Speaker:

might have been in that nucleus.

Speaker:

Whether it was polygenic, whether it was

Speaker:

chromosomal, whether it was point

Speaker:

mutations, frame shift mutation, didn't

Speaker:

make any difference.

Speaker:

When that cancer nucleus was placed into

Speaker:

the cytoplasm of a non-cancerous cell,

Speaker:

that new cell no longer

Speaker:

had dysregulated cell growth.

Speaker:

That's quite interesting.

Speaker:

And that's been done repeatedly.

Speaker:

And in vivo and in vitro.

Speaker:

So in all kinds of experimental systems,

Speaker:

meaning that normal cytoplasm

Speaker:

suppresses neoplastic growth.

Speaker:

On the other hand, if the nucleus of a

Speaker:

normal cell is now placed in the

Speaker:

cytoplasm of a tumor cell, you've got

Speaker:

dysregulated growth,

Speaker:

which is completely the opposite of what

Speaker:

you would have expected on

Speaker:

the somatic mutation theory.

Speaker:

So when you have the opportunity to sit

Speaker:

down and carefully evaluate all of the

Speaker:

evidence from the nuclear mitochondrial

Speaker:

transfer experiments, also, if you have a

Speaker:

raging tumor cell and you replace the

Speaker:

mitochondria with normal mitochondria,

Speaker:

just put normal mitochondria, you get

Speaker:

complete downregulation of this

Speaker:

dysregulated growth.

Speaker:

You can convert a raging tumor cell into

Speaker:

an indolent tumor cell by putting normal

Speaker:

mitochondria back in the cytoplasm,

Speaker:

mitochondrial medicine type.

Speaker:

I was about to say, I'm getting ahead of

Speaker:

my curve and I'm going to shoot myself in

Speaker:

the foot by asking this question now, but

Speaker:

just with regards to that, then, is there

Speaker:

any thought to the idea that

Speaker:

mitochondrial transplants could be a

Speaker:

potential therapy in that regard?

Speaker:

Absolutely.

Speaker:

But that's the future.

Speaker:

It's not here yet, because we have to

Speaker:

make sure that the mitochondria that are

Speaker:

transplanted are normal in numbers,

Speaker:

structure, and function.

Speaker:

And during the very process of

Speaker:

manipulating these

Speaker:

mitochondria, you can also damage them.

Speaker:

And you have to know how to do that.

Speaker:

So mitochondrial medicine

Speaker:

is going to be the future.

Speaker:

But where the technology

Speaker:

to do that is not here yet.

Speaker:

So our approach to managing cancer is

Speaker:

killing the tumor cells while not harming

Speaker:

the rest of the body and then allowing

Speaker:

people to live far longer with a higher

Speaker:

quality of life, while mitochondrial

Speaker:

medicine is under development.

Speaker:

That's the thing.

Speaker:

It's very interesting, because when you

Speaker:

have dysregulated cell growth in cancer,

Speaker:

they're fermenting like crazy.

Speaker:

And the oncogenes, which have generated

Speaker:

tremendous interest, we have shown, and

Speaker:

others, HIF1, alpha, MIC, and these

Speaker:

things, they are there.

Speaker:

And they are facilitators of opening the

Speaker:

floodgates for fermentation

Speaker:

fuels to get into the cell.

Speaker:

And when you put new mitochondria into

Speaker:

the cell, the oncogenes turn off.

Speaker:

You don't need them anymore.

Speaker:

Why are you going to

Speaker:

ferment when I can respire?

Speaker:

So the oncogenes are no longer needed.

Speaker:

And normal mitochondrial respiration turn

Speaker:

off oncogene expression.

Speaker:

So you shut down the glycolysis and the

Speaker:

glutaminolysis pathways, because you

Speaker:

don't need glucose and glutamine.

Speaker:

You can respire.

Speaker:

Everything makes perfect sense.

Speaker:

And the data show that.

Speaker:

So where did all the mutations come from?

Speaker:

They came from the biology of inefficient

Speaker:

oxidative phosphorylation, throwing out

Speaker:

reactive oxygen species, which is the

Speaker:

superoxide and the anion, the OH radical,

Speaker:

which are carcinogenic and mutagenic.

Speaker:

And they come out of the dysfunctional

Speaker:

mitochondria, creating an escalating

Speaker:

situation of biological chaos.

Speaker:

So what we're seeing, or what the field

Speaker:

is mostly focusing on, is downstream

Speaker:

epiphenomena of the damage to

Speaker:

mitochondria and all the

Speaker:

sequelae that follow that.

Speaker:

It's really amazing to me.

Speaker:

I just can't figure out how the field

Speaker:

doesn't understand this.

Speaker:

I try to, I don't know, maybe

Speaker:

I have to write it in crayon.

Speaker:

Sometimes you just have to do that.

Speaker:

You have to take the back of a neck and

Speaker:

smash the guy's face into

Speaker:

the evidence to let him see it.

Speaker:

But the interesting thing is that you see

Speaker:

all these clear evidence that you can

Speaker:

manage this disease quite effectively by

Speaker:

just depriving the cell of the two

Speaker:

fermentable fuels that it needs and then

Speaker:

transitioning the whole body over the

Speaker:

fuels that the tumor cells can't use.

Speaker:

So intrinsically,

Speaker:

people say, oh, cancer cells are so tough

Speaker:

and hardy, and they're so versatile.

Speaker:

That's total crap.

Speaker:

How do you explain a cell with a nucleus

Speaker:

blown to hell with all these mutations?

Speaker:

And you're going to

Speaker:

have that cell behave more

Speaker:

transitional and more flexible than the

Speaker:

cells in our body that evolved over

Speaker:

millions of years to adjust their

Speaker:

metabolism to the situation.

Speaker:

And the cancer cell can do this with a

Speaker:

nucleus that's blown to hell.

Speaker:

Makes no sense in evolutionary biology.

Speaker:

People don't

Speaker:

understand evolutionary biology.

Speaker:

The way you understand cancer and many

Speaker:

other diseases, you must understand

Speaker:

evolutionary biology.

Speaker:

And if you don't do that,

Speaker:

you're going to be in the dark.

Speaker:

You're going to be in the dark.

Speaker:

And that explains a lot of the stuff that

Speaker:

we have in medicine today, because people

Speaker:

don't understand evolutionary biology.

Speaker:

They remain in the dark.

Speaker:

And as long as you remain in the dark,

Speaker:

you ain't moving forward.

Speaker:

So here's what they say.

Speaker:

Oh, cancer cells are tough to kill

Speaker:

because we're throwing everything at

Speaker:

radiation and chemo and immunotherapies.

Speaker:

And those damn cancer cells can survive.

Speaker:

They're protecting themselves with the

Speaker:

waste products of

Speaker:

fermentation metabolism.

Speaker:

Everybody knows.

Speaker:

They say, oh, the cancer environment is

Speaker:

so acidified, it protects them from the

Speaker:

therapies that we have.

Speaker:

Where does the acidification come from?

Speaker:

The waste products of glucose and

Speaker:

glutamine fermentation.

Speaker:

If you take away glucose and glutamine,

Speaker:

you remove the acidification of the micro

Speaker:

environment, making the tumor cells

Speaker:

extremely vulnerable to small doses of

Speaker:

radiation, chemo, and

Speaker:

these other procedures.

Speaker:

How is that not understood by guys that

Speaker:

are supposed to be smart?

Speaker:

Don't you understand why the damn tumor

Speaker:

cells are not dying from

Speaker:

what you're throwing at them?

Speaker:

Because they're fermenting.

Speaker:

If they ferment, you take

Speaker:

away the fermentable fuels.

Speaker:

Oh, that can't be right.

Speaker:

It's too simple.

Speaker:

Yeah.

Speaker:

And it works.

Speaker:

And it is right.

Speaker:

Get over it.

Speaker:

You want to live longer, you take away

Speaker:

the fermentable fuels, and then you give

Speaker:

them fatty acids and ketones, and the

Speaker:

cancer cell can't because

Speaker:

you need a good mitochondria.

Speaker:

Fatty acids and ketone bodies cannot be

Speaker:

used as a fuel by cancer cells because

Speaker:

the mitochondria are inefficient.

Speaker:

Fatty acids and ketone bodies can be used

Speaker:

by most of our normal cells because we

Speaker:

have good

Speaker:

mitochondria, healthy mitochondria.

Speaker:

So we lower the blood sugar, elevate the

Speaker:

ketones, and then come in and target the

Speaker:

glutamine pathways strategically in an

Speaker:

approach that we developed, the press

Speaker:

pulse therapeutic strategy.

Speaker:

Glucose is a non-essential metabolite.

Speaker:

Glucose is a non-essential metabolite.

Speaker:

We can live with very, very minimal

Speaker:

levels of glucose just to keep our

Speaker:

erythrocytes moving oxygen

Speaker:

and CO2 through the body.

Speaker:

It takes tiny amounts of glucose.

Speaker:

But the majority of muscles and brain can

Speaker:

all transition over to ketone bodies.

Speaker:

Tumor cells cannot.

Speaker:

We tested them.

Speaker:

We interrogated these cells.

Speaker:

Tumor cells collect huge droplets of

Speaker:

fatty acids in the cytoplasm because they

Speaker:

cannot use the fatty acids.

Speaker:

If you force the tumor cell to use the

Speaker:

fatty acids, it develops reactive oxygen

Speaker:

species and explodes and dies.

Speaker:

So that's why they store the fatty acids

Speaker:

in the cytoplasm because if they try to

Speaker:

use them, they're going to kill them.

Speaker:

So this is simply a protective mechanism.

Speaker:

I can't tell you how many people are

Speaker:

writing papers saying tumor cells love

Speaker:

fatty acids because they store them in

Speaker:

the cytoplasm because

Speaker:

they need them for fuel.

Speaker:

Yeah, well, try to goose the cell to use

Speaker:

the fatty acids and all

Speaker:

of a sudden the cell dies.

Speaker:

Try to grow your cells, your cancer cells

Speaker:

in the absence of glucose and glutamine

Speaker:

in the presence of fatty

Speaker:

acids in ketone bodies.

Speaker:

With no glucose, no

Speaker:

fermentable fuels, they die.

Speaker:

So it becomes very

Speaker:

clear how to manage cancer.

Speaker:

So we're aware of this.

Speaker:

Unfortunately, the field still has to

Speaker:

come to grips with this

Speaker:

and I think they slowly are,

Speaker:

but it takes time, unfortunately.

Speaker:

Yeah, I know.

Speaker:

I think we could

Speaker:

probably stop the podcast there.

Speaker:

That was incredible.

Speaker:

Thank you.

Speaker:

I'm definitely going to have

Speaker:

to re-listen to a bunch of that.

Speaker:

Well, not only listen, not only re-listen

Speaker:

to it, read the damn

Speaker:

papers that we published.

Speaker:

I go into great biochemical details.

Speaker:

I have the evidence put out in those

Speaker:

papers that we published

Speaker:

and they're open access.

Speaker:

So everybody can read them.

Speaker:

Anybody with a few functional brain cells

Speaker:

can sit down and read these papers and

Speaker:

make their own decision as to what they

Speaker:

think in light of that.

Speaker:

I do a compare and contrast the theories.

Speaker:

I do the evidence supporting the

Speaker:

different theories and you tell me what

Speaker:

you think is happening.

Speaker:

And I learned there's very few people

Speaker:

that actually understand or not

Speaker:

understand that who read

Speaker:

actually read the literature.

Speaker:

They all wait and they only do what other

Speaker:

people are doing and they ask other

Speaker:

people what they think.

Speaker:

And if the person

Speaker:

says, "Oh, no, it can't be.

Speaker:

Okay, then I believe it can't be."

Speaker:

Why don't you use your own brain cells

Speaker:

and analyze the data for yourself?

Speaker:

That's one of the great things about

Speaker:

humans is we have a rational mind.

Speaker:

That's what we were gifted with.

Speaker:

But I'll tell you, dogmatic views,

Speaker:

political, religion, all that takes away

Speaker:

from rational thinking.

Speaker:

And when you lose your ability to sit and

Speaker:

rationalize, then you

Speaker:

lose a part of your humanity.

Speaker:

And what we're seeing here, the reason

Speaker:

why there's a delay in the movement from

Speaker:

the somatic mutation theory to the

Speaker:

mitochondrial metabolic theory, which

Speaker:

will prevent and manage

Speaker:

diseases dramatically.

Speaker:

We're going to drop cancer death rates

Speaker:

like there's no tomorrow.

Speaker:

We're going to keep people alive because

Speaker:

we understand the science

Speaker:

supporting what we're saying.

Speaker:

And then once people start looking at it

Speaker:

and seeing that we are essentially

Speaker:

correct, not on all the minutia, we can

Speaker:

always work out minutia later on.

Speaker:

But the bottom line is how long can I

Speaker:

keep somebody with a

Speaker:

stage four tumor alive?

Speaker:

Oh, he's got three months to live.

Speaker:

Are you kidding me?

Speaker:

We've got people that were given those

Speaker:

days, they're still alive five and six

Speaker:

years later because they've transitioned

Speaker:

their body over to nutritional ketosis

Speaker:

and came in with certain low dose

Speaker:

medications to kill off the tumor cells.

Speaker:

So I know it's going to work because I've

Speaker:

seen enough preclinical studies and human

Speaker:

studies, small trials, to know this will

Speaker:

work and keeps people alive.

Speaker:

Unfortunately, you go to the top

Speaker:

hospitals and they tell you,

Speaker:

oh, no, you got to have this.

Speaker:

Did you ever hear the

Speaker:

cancer is a med about?

Speaker:

No, I never heard of it.

Speaker:

Eat sugar, eat all the

Speaker:

high carbohydrate diets.

Speaker:

Why?

Speaker:

Oh, because you're losing weight.

Speaker:

Why am I losing weight?

Speaker:

Well, you have cancer and

Speaker:

we just try to poison you.

Speaker:

Anybody who's poisoned loses weight.

Speaker:

So you get nausea and

Speaker:

vomiting, diarrhea, fatigue.

Speaker:

Why are you doing that?

Speaker:

Well, we use the toxic poison on you.

Speaker:

Why are you doing that?

Speaker:

Well, we're trying to

Speaker:

kill your tumor cells.

Speaker:

I went bald.

Speaker:

Why?

Speaker:

Why you go bald?

Speaker:

I lost all my hair.

Speaker:

Oh, did you have tumor cells growing in

Speaker:

your hair follicles?

Speaker:

No, they just happened to die.

Speaker:

You're trying to kill tumor cells, not

Speaker:

kill your hair or blow out your gut.

Speaker:

That tells you that those are the

Speaker:

procedures of people who lack knowledge.

Speaker:

What we're seeing is the result of

Speaker:

massive lack of knowledge on the

Speaker:

biochemistry and biology of the very

Speaker:

disease that people are working with.

Speaker:

And we're using medieval therapies that

Speaker:

are torturing people.

Speaker:

I think people during the Spanish

Speaker:

Inquisition would be very impressed with

Speaker:

how we're torturing cancer

Speaker:

patients in these hospitals.

Speaker:

They could say, "Well, we can learn

Speaker:

something from you guys.

Speaker:

Where do I get Red Devil Doxorubicin?

Speaker:

We could give that to a heretic."

Speaker:

It's terrible for me

Speaker:

to say stuff like this.

Speaker:

But when you see 1700 people a day in the

Speaker:

United States dying from cancer, 70

Speaker:

people an hour, and you see cancer

Speaker:

getting worse and worse around the world,

Speaker:

I mean, grab somebody by the throat and

Speaker:

say, "What the hell are we doing?

Speaker:

Why are we allowing this to happen?"

Speaker:

Because of a failed theory.

Speaker:

That's what it is, a theory that's no

Speaker:

longer supported by the evidence.

Speaker:

And you guys keep treating people based

Speaker:

on an incorrect theory,

Speaker:

and the outcome is abysmal.

Speaker:

Yeah.

Speaker:

What did Einstein say?

Speaker:

Insanity is doing the same thing over and

Speaker:

over again and expecting a different

Speaker:

result, something to that extent.

Speaker:

Yes.

Speaker:

Well, why are they doing?

Speaker:

Don't they know what Einstein said?

Speaker:

Did they not hear what Einstein said?

Speaker:

And there's another issue of morality,

Speaker:

which is even a worse issue.

Speaker:

You don't like to be referred to as an

Speaker:

immoral person, but when you're taking

Speaker:

drugs that are not based on the correct

Speaker:

theory and treating people with them and

Speaker:

knowing that they won't work,

Speaker:

and that's immoral.

Speaker:

And the other part of this is that many

Speaker:

of those drugs are very, very expensive.

Speaker:

And what happens, they not only cause

Speaker:

physical toxicity, they

Speaker:

cause financial toxicity.

Speaker:

Many people, their marriage is dissolved,

Speaker:

they commit suicide, the cost is passed

Speaker:

on to the surviving relatives.

Speaker:

And for folks that are not well off, a

Speaker:

$20,000 bill, even though they covered

Speaker:

80% of the 100,000,

Speaker:

20,000 can cripple a family.

Speaker:

With limited means.

Speaker:

This is immoral.

Speaker:

The whole cancer

Speaker:

industry is an immoral industry.

Speaker:

They're allowing people to suffer and die

Speaker:

based on an incorrect theory.

Speaker:

And they're allowing

Speaker:

physical and financial toxicity.

Speaker:

These are immoral acts.

Speaker:

And we have a strategy that can

Speaker:

absolutely reduce the deaths of cancer,

Speaker:

keep people alive with a higher quality

Speaker:

of life, and it's not being

Speaker:

done anywhere on the planet.

Speaker:

Now you tell me what's wrong with that.

Speaker:

Yeah, I'm not even going to try and sort

Speaker:

of answer that

Speaker:

question just at this point.

Speaker:

Dr.

Speaker:

Seifried, again, that

Speaker:

was an amazing answer.

Speaker:

Thank you.

Speaker:

I'd just like to take a step back quickly

Speaker:

and discuss, have a quick discussion

Speaker:

about your thoughts on testing.

Speaker:

Now, the way I see testing, testing is

Speaker:

generally done quite acutely when

Speaker:

somebody presents with

Speaker:

a disease in this case.

Speaker:

You'll obviously get a physical exam

Speaker:

done, some sort of imaging, probably some

Speaker:

sort of biopsy as well, some blood tests

Speaker:

looking at various biomarkers, et cetera.

Speaker:

But in no way is this

Speaker:

sort of testing preventative.

Speaker:

It generally is only treated and dealt

Speaker:

with when the issues arise.

Speaker:

Now, obviously, there are various

Speaker:

technologies that are starting to sort of

Speaker:

come up to things like liquid biopsies.

Speaker:

Maybe you could elucidate on that

Speaker:

slightly and these full-body MRIs, which

Speaker:

are obviously somewhat controversial in

Speaker:

the sense that they may or

Speaker:

may not pick up incident lomas.

Speaker:

The idea of finding an issue that may not

Speaker:

be an issue that then requires further

Speaker:

investigation that then may or may not

Speaker:

actually turn into an issue.

Speaker:

What's your stance on

Speaker:

early detection as a whole?

Speaker:

Do you think it's something we should be

Speaker:

exploring more beyond just the basic get

Speaker:

your colonoscopy done

Speaker:

when you hit 40 plus?

Speaker:

Or does the whole thing again about

Speaker:

incident lomas and treating cancer from

Speaker:

that perspective and, excuse me, treating

Speaker:

and scanning for cancer from that

Speaker:

perspective generally make

Speaker:

it a bit of a mute point?

Speaker:

Yeah, well, you have a couple

Speaker:

of things here to break down.

Speaker:

The diagnostics, I'm in favor of

Speaker:

non-invasive diagnostic approaches.

Speaker:

If we have a liquid biopsy that's 95%

Speaker:

accurate in determining whether or not

Speaker:

you have a neoplastic growth somewhere in

Speaker:

your body, I'm all for that.

Speaker:

And then non-invasive imaging, whether

Speaker:

it's a PET scan, MRI, CAT scan, or one of

Speaker:

these kinds of things, I'm not in favor

Speaker:

of biopsy because I have seen so many

Speaker:

papers published in the scientific

Speaker:

literature showing that when you stab a

Speaker:

cancer, you run the risk of causing

Speaker:

metastasis, metastasis where the spread

Speaker:

of the tumor, the cells can spread around

Speaker:

your body making what was formerly a

Speaker:

localized problem, a systemic problem.

Speaker:

So I'm in favor of four diagnostics,

Speaker:

colonoscopies and and breast

Speaker:

things and stuff like this.

Speaker:

Those are, you know, I

Speaker:

don't know what to say

Speaker:

about that.

Speaker:

I know there's a lot of

Speaker:

controversy about that.

Speaker:

And most people who develop cancer have

Speaker:

certain physical signs in

Speaker:

their body that something is wrong.

Speaker:

Like you said, a lump,

Speaker:

a wound that doesn't heal blood that

Speaker:

continues to come from some location.

Speaker:

You know, those can be then liquid biopsy

Speaker:

to see if there's a real linkage to some

Speaker:

neoplasia, a scanning of the body or

Speaker:

something along these lines.

Speaker:

And then once you would make a diagnosis

Speaker:

without a biopsy, you see a lump.

Speaker:

Okay, let's launch into metabolic therapy

Speaker:

and see if we can shrink the lump

Speaker:

naturally with diet drug combinations,

Speaker:

non-toxic drugs and diets that we've

Speaker:

developed here at BC.

Speaker:

And if you shrink the lump and it goes

Speaker:

away, and the imaging analysis and the

Speaker:

liquid biopsy data, what happened?

Speaker:

Where did it go?

Speaker:

I don't see any of the

Speaker:

markers that were there previously.

Speaker:

That's great.

Speaker:

And if it doesn't go away completely,

Speaker:

you might have shrunken it down and make

Speaker:

it much smaller, in which case a surgical

Speaker:

procedure or a dose of radiation at a

Speaker:

very defined spot could

Speaker:

be potentially curative.

Speaker:

So there's a lot of ways to diagnose and

Speaker:

treat cancer in the early stages

Speaker:

different than what we're doing today.

Speaker:

You know, we're doing too

Speaker:

radical on this whole thing.

Speaker:

You know, you see a lump in the rip the

Speaker:

person's breasts off

Speaker:

or something like this.

Speaker:

You know, I don't know what to say about

Speaker:

colonoscopies or breast exam exams.

Speaker:

Breast cancer rises every

Speaker:

year in females in this country.

Speaker:

Colorectal cancer is on the rise.

Speaker:

So I don't know what's going on.

Speaker:

All the major cancers seem to be, many of

Speaker:

the major cancers seem to be on the rise.

Speaker:

It's happening in

Speaker:

younger and younger people.

Speaker:

Yeah, if you're to speculate, do you

Speaker:

think that is an environmental issue,

Speaker:

just sort of maybe excess sort of

Speaker:

zenoestrogens in the environment that are

Speaker:

particularly just from a breast cancer

Speaker:

perspective, maybe

Speaker:

triggering these issues?

Speaker:

Or is that a bit productionist again?

Speaker:

I think most of it is environmental.

Speaker:

I mean, there are some people who have

Speaker:

genetic predispositions to

Speaker:

insults from the environment.

Speaker:

You have to realize

Speaker:

that cancer is a disease.

Speaker:

In fact, not only cancer, most of the

Speaker:

chronic diseases that we are dealing

Speaker:

with, which is dementia, type 2 diabetes,

Speaker:

obesity, hypertension, high blood

Speaker:

pressure, a lot of neuropsychiatric

Speaker:

problems, are all the result of

Speaker:

mitochondrial dysfunction in one way or

Speaker:

another, caused by the diet lifestyle

Speaker:

that we're all under.

Speaker:

And we know this pretty much because

Speaker:

Paleolithic men would not have had any of

Speaker:

these kinds of conditions.

Speaker:

They died predominantly

Speaker:

from infections and injuries.

Speaker:

They did not have orthopedic surgeons to

Speaker:

repair a broken knee from

Speaker:

some guy gored by a buffalo.

Speaker:

And how do we know that?

Speaker:

Because people say, "Well, you weren't

Speaker:

there during Paleolithic

Speaker:

period 500,000 years ago."

Speaker:

But we have people on the planet who

Speaker:

still live, according

Speaker:

to traditional ways.

Speaker:

And these folks also didn't have cancer

Speaker:

or a lot of the chronic

Speaker:

diseases that we have today.

Speaker:

How do we know that?

Speaker:

Because Albert Schweitzer and a number of

Speaker:

other physicians and humanitarians were

Speaker:

investigating these primitive tribes.

Speaker:

And they said, "Wow, they're remarkably

Speaker:

different from those that live in the

Speaker:

United States and England."

Speaker:

So they were not obese.

Speaker:

They didn't have any chronic diseases.

Speaker:

They had bacterial infections, parasites,

Speaker:

and things like this.

Speaker:

So what's the difference between the

Speaker:

Western diet lifestyle and the

Speaker:

Paleolithic diet and lifestyle?

Speaker:

And predominantly, it's the availability

Speaker:

of highly processed

Speaker:

carbohydrates in our diets.

Speaker:

A Paleolithic man never had highly

Speaker:

processed carbohydrates in his diet.

Speaker:

We did not evolve to evolve in an

Speaker:

environment with highly processed carbs.

Speaker:

But highly processed carbohydrates, are

Speaker:

you talking, obviously,

Speaker:

and my evolution biology is definitely

Speaker:

not my strong point, but I assume you

Speaker:

mean very high GI carbohydrates, things

Speaker:

like your processed sugars, honeys, etc.,

Speaker:

opposed to things like root vegetables,

Speaker:

things that are potentially

Speaker:

lower on the glycemic scale.

Speaker:

That maybe wouldn't...

Speaker:

Yes, predominantly.

Speaker:

Things that can

Speaker:

remain edible in a package.

Speaker:

Like I have a Twinkie here.

Speaker:

This Twinkie is 10 years

Speaker:

old, and it looks edible.

Speaker:

And a mouse, it's 10 years old, and a

Speaker:

mouse ate it, broke in and ate one of

Speaker:

these two years ago.

Speaker:

And he didn't complain.

Speaker:

And there are people that are hungry that

Speaker:

would eat 10 year old Twinkie.

Speaker:

This is a synthetic thing made from all

Speaker:

chemicals and sugars.

Speaker:

This kind of stuff will kill you.

Speaker:

Yet we eat large amounts of it.

Speaker:

Not only that, we deep fry it and put

Speaker:

powdered sugar and

Speaker:

chocolate syrup on it, damn thing.

Speaker:

You should go to Scotland.

Speaker:

That's the Shon's Act breakfast.

Speaker:

Yeah, right.

Speaker:

So then we wonder why we got cancer and

Speaker:

high blood pressure and hypertension and

Speaker:

neuropsychiatric problems.

Speaker:

And the lack of exercise is unbelievable.

Speaker:

Paleo, you know how hard it is to track

Speaker:

down and kill a big animal?

Speaker:

It's not easy.

Speaker:

You have to have well runners.

Speaker:

You have to have strong guys to track

Speaker:

down and kill these buffalo.

Speaker:

And you have to kill a mammoth, a woolly

Speaker:

mammoth, and these kinds of big animals

Speaker:

that lived in paleolithic times.

Speaker:

And that was a lot of energy to kill, not

Speaker:

only to kill the big thing,

Speaker:

but to chop it up and eat it.

Speaker:

You know, they'd go for the bone marrow

Speaker:

as a fuel source that

Speaker:

was very rich in nutrients.

Speaker:

We're sitting in traffic today.

Speaker:

We're sitting in front of computers.

Speaker:

We don't nearly have the amount of energy

Speaker:

that was expended

Speaker:

during paleolithic times.

Speaker:

We're eating highly

Speaker:

processed carbs, bad food.

Speaker:

We have bad sleep.

Speaker:

We have emotional stress.

Speaker:

We have all of these things that impact

Speaker:

negatively the number structure and

Speaker:

function of mitochondria in our cells.

Speaker:

It is not surprising that we have all of

Speaker:

the chronic diseases in cancer that we

Speaker:

are currently suffering with

Speaker:

in modern Western societies.

Speaker:

It's absolutely understandable in terms

Speaker:

of our evolutionary biology.

Speaker:

We are still paleolithic man

Speaker:

biologically, but living in a modern,

Speaker:

industrialized society where all of the

Speaker:

desires that we would have had in

Speaker:

paleolithic time are now at our

Speaker:

fingertips in any supermarket.

Speaker:

We don't have to go out

Speaker:

and hunt down animals.

Speaker:

Everything is prepared, packaged, and

Speaker:

ready for us to eat right away.

Speaker:

We don't have to expend a lot of energy

Speaker:

to cook it up, kill it,

Speaker:

and cook it every night.

Speaker:

It's preserved, well preserved, so we can

Speaker:

store it for a long

Speaker:

period of time and eat it.

Speaker:

Eventually, it beats the hell out of your

Speaker:

mitochondria in your body.

Speaker:

Some people, you get obesity, type 2

Speaker:

diabetes, hypertension, high blood

Speaker:

pressure, macular

Speaker:

degeneration, dementia, cancer.

Speaker:

Every one of those diseases, disorders,

Speaker:

is the result of mitochondrial

Speaker:

dysfunction in one way or another.

Speaker:

Some cells up and die become

Speaker:

dysfunctional, not becoming cancer.

Speaker:

Some cells that have the capacity to

Speaker:

switch from oxfoss to substrate-level

Speaker:

phosphorylation become cancerous.

Speaker:

We can link all of the major chronic

Speaker:

diseases, including cancer, back to

Speaker:

mitochondrial dysfunction, which then

Speaker:

begs the question, well,

Speaker:

how do you prevent cancer?

Speaker:

And you keep your mitochondria healthy.

Speaker:

It's extremely difficult to get cancer if

Speaker:

you're mitochondria healthy.

Speaker:

Well, how do I keep my

Speaker:

mitochondrial healthy?

Speaker:

Do a lot of exercise, stress management,

Speaker:

avoid highly processed carbohydrate

Speaker:

foods, try to get good sleep.

Speaker:

Do all the things that keep mitochondria

Speaker:

healthy, and you don't get dementia, you

Speaker:

don't get cardiovascular

Speaker:

disease, you don't become obese,

Speaker:

you don't get cancer.

Speaker:

You significantly reduce the risk for

Speaker:

cancer and all these chronic diseases by

Speaker:

keeping your mitochondria healthy.

Speaker:

It's very interesting.

Speaker:

In the United States,

Speaker:

the NCI National Cancer Institute says,

Speaker:

"We reduce cancer by 33% over the last

Speaker:

several decades, mainly because we had

Speaker:

the anti-smoking campaign of the 1990s.

Speaker:

And if we all continue to smoke like

Speaker:

crazy, like we were in the 1990s, we

Speaker:

would have 33% more dead cancer patients

Speaker:

today than we actually have."

Speaker:

So clearly, the major drop in cancer

Speaker:

deaths came from the

Speaker:

elimination of a provocative

Speaker:

behavioral situation, which was smoking.

Speaker:

So why?

Speaker:

Because our mitochondria are healthier

Speaker:

when you don't smoke.

Speaker:

And everything comes back to the health

Speaker:

and vitality of the mitochondria.

Speaker:

Do we want to go back and become, again,

Speaker:

live in a cave like Paleolithic Man?

Speaker:

No.

Speaker:

No,

Speaker:

but finding that happy middle ground.

Speaker:

Yes.

Speaker:

But now we have an awareness.

Speaker:

And not only that, we develop the glucose

Speaker:

ketone index calculator.

Speaker:

My next question was

Speaker:

going to be exactly that.

Speaker:

Which is now going to be the tool to

Speaker:

allow every person that can measure their

Speaker:

blood, glucose, and ketones with a meter,

Speaker:

either by pricking their finger to get a

Speaker:

drop of blood or using a continuous

Speaker:

glucose ketone monitor on your cell

Speaker:

phone, you will be able to know when you

Speaker:

apply the GKI index, you will know

Speaker:

exactly what zone of

Speaker:

health you are in or not in.

Speaker:

So you can know that you will be in a

Speaker:

high risk red zone if you have a GKI

Speaker:

that's over 50, up to 100.

Speaker:

You are going to be in a zone of

Speaker:

mitochondrial ill health.

Speaker:

Can we backtrack quickly, Dr.

Speaker:

Seifried?

Speaker:

Sorry about that.

Speaker:

Just briefly discuss what the glucose

Speaker:

ketone index is, just for those in the

Speaker:

audience who maybe

Speaker:

aren't familiar with it.

Speaker:

Obviously, it's a biomarker that I know

Speaker:

you have been intimately

Speaker:

involved in developing.

Speaker:

But what exactly is this

Speaker:

index and then how does it work?

Speaker:

Obviously, we are monitoring two

Speaker:

different biomarkers here, ketones,

Speaker:

things like butyl

Speaker:

hydroxybutyrate, acetate, etc.

Speaker:

And then obviously glucose.

Speaker:

But how does looking at those two markers

Speaker:

from a metabolic health standpoint help

Speaker:

us to, well, a, determine metabolic

Speaker:

health and maybe just a

Speaker:

bit more nuance there.

Speaker:

I know there's

Speaker:

generally a range there as well.

Speaker:

I think you want to aim for about a three

Speaker:

when looking to try and deal

Speaker:

with things therapeutically.

Speaker:

I may be wrong there.

Speaker:

But yeah, if you could just fill us in

Speaker:

sort of very fiduciary on

Speaker:

what that index is all about.

Speaker:

So again, go back to

Speaker:

evolutionary biology.

Speaker:

Paleolithic man was always in a state of

Speaker:

nutritional ketosis, mainly because they

Speaker:

did not have access to highly processed

Speaker:

carbohydrates in their diet.

Speaker:

So they had a lot of exercise and they

Speaker:

had a diet that was largely carnivorous

Speaker:

with some vegetables, some

Speaker:

tubers and this kind of thing.

Speaker:

But they were complex carbs.

Speaker:

They weren't these highly processed, like

Speaker:

you mentioned already, highly glycemic

Speaker:

index kinds of things.

Speaker:

And food was limited.

Speaker:

So when you put that body and you look at

Speaker:

the, if they could look at their glucose

Speaker:

and ketones at that stage, they would

Speaker:

find themselves in a state of nutritional

Speaker:

ketosis, which is an elevation of ketone

Speaker:

bodies and a very low glucose level, or I

Speaker:

should say very normal, like 65 to 85

Speaker:

milligram per deciliter, maybe

Speaker:

a 3.2 to 4 millimolar glucose.

Speaker:

These are normal body levels of glucose

Speaker:

produced by the combination of

Speaker:

gluconeogenesis as well as carbohydrates

Speaker:

that we would get from the diet.

Speaker:

So we would always be in this beautiful

Speaker:

insulin, super insulin sensitive zone, no

Speaker:

insulin resistance at all, because

Speaker:

diabetes would be unheard of, type two,

Speaker:

of course, not type one.

Speaker:

Type one would have been afflicting us

Speaker:

from the beginning of

Speaker:

time in one way or another.

Speaker:

But our bodies would have been in

Speaker:

metabolic homeostasis as long as we

Speaker:

weren't starving, of course.

Speaker:

But we could go long periods of time

Speaker:

without eating and still maintain

Speaker:

metabolic homeostasis because we would be

Speaker:

burning ketone bodies that would be

Speaker:

mobilized from stored fat.

Speaker:

So we developed the glucose ketone index

Speaker:

as a marker, biomarker, to allow us to

Speaker:

know what level of metabolic

Speaker:

homeostasis we would be in.

Speaker:

So if you have a glucose ketone index of

Speaker:

20 or 10, I mean, you're in some level of

Speaker:

metabolic homeostasis.

Speaker:

If you want to go into a deeper level of

Speaker:

what we call therapeutic ketosis, then

Speaker:

you'd go down to a level of two, which is

Speaker:

the ratio of blood sugar divided by the

Speaker:

ratio of beta hydroxybutyrate, which is

Speaker:

the main ketone body.

Speaker:

And then you would say,

Speaker:

oh, how do we know this?

Speaker:

Because I have friends, Dom DiAgostino,

Speaker:

Anthony Chapp in these guys, they're

Speaker:

always in these states

Speaker:

of nutritional ketosis.

Speaker:

What do they do?

Speaker:

They do a lot of exercise

Speaker:

and they eat a lot of meat.

Speaker:

And they stay in these

Speaker:

paleolithic kinds of zones.

Speaker:

And these are the zones that keep your

Speaker:

mitochondria super healthy.

Speaker:

So what we do is we take people from the

Speaker:

population and look at guys that have

Speaker:

type 2 diabetes,

Speaker:

obesity, and all these things.

Speaker:

And you find these GKI values over 50,

Speaker:

100, sometimes above 100.

Speaker:

Are you kidding me?

Speaker:

I mean, it should be down in

Speaker:

the 5 to 10 zone or 20 zone.

Speaker:

And you've got 200?

Speaker:

Oh, I'm obese.

Speaker:

I got systemic inflammation.

Speaker:

I got to, of course, you're not in

Speaker:

metabolic homeostasis.

Speaker:

So the glucose ketone index tells us I

Speaker:

built it for the cancer patients, because

Speaker:

we knew that if we lowered blood sugar

Speaker:

down far enough, the tumor cells need the

Speaker:

sugar to grow, and they

Speaker:

can't switch to ketones.

Speaker:

So you put them in a

Speaker:

very compromised condition.

Speaker:

Now, what we do is we see cancer

Speaker:

shrinking down tremendously when you get

Speaker:

the GKI 2.0 or below,

Speaker:

but you still have the glutamine issue.

Speaker:

So then we develop the pulse therapy to

Speaker:

come in and target with low dose of

Speaker:

glutamine inhibitors while the person is

Speaker:

in a state of nutritional ketosis.

Speaker:

And glutamine being the fermentable amino

Speaker:

acid that is then utilized as an

Speaker:

alternative fuel source by various

Speaker:

cancers in the absence

Speaker:

of glucose is accurate.

Speaker:

Yeah.

Speaker:

And people always ask me, what can you do

Speaker:

to lower, what diet can

Speaker:

I use to lower glutamine?

Speaker:

And if I eat meat,

Speaker:

won't that raise glutamine?

Speaker:

The glutamine in our body is already

Speaker:

super saturated because we use it for so

Speaker:

many things, the gut

Speaker:

and our immune system.

Speaker:

We already have more than enough

Speaker:

glutamine circulating in the body to

Speaker:

provide a tumor cell with more than

Speaker:

enough fuel in that regard.

Speaker:

So there's no diet that will lower

Speaker:

glucose, correction glutamine.

Speaker:

And the glutamine will always be there.

Speaker:

So you can't, even if you do exercise,

Speaker:

yes, you can lower glutamine, but it's

Speaker:

not to the level where you're going to

Speaker:

kill the tumor cell.

Speaker:

So that's why we need drugs.

Speaker:

But the drugs have to be strategic.

Speaker:

While you're in nutritional ketosis,

Speaker:

blood sugar is down,

Speaker:

ketones are elevated.

Speaker:

So you got a choke hold

Speaker:

on the glucose pathway.

Speaker:

But you got the

Speaker:

glutamine pathway still opened.

Speaker:

And then we come in with specific drugs

Speaker:

that will block glutamine's availability.

Speaker:

But we have to do this very strategically

Speaker:

because the same fuel is

Speaker:

needed by our immune cells.

Speaker:

Our immune cells and our gut use the same

Speaker:

fuel the tumor cells are using.

Speaker:

So that's why we

Speaker:

developed the press pulse.

Speaker:

So we pulse glutamine.

Speaker:

We do pulsing of glutamine targeting,

Speaker:

killing tumor cells over a short period

Speaker:

of time, removing the pulse, and allowing

Speaker:

the immune system to come in and kill, to

Speaker:

pick up the dead corpses.

Speaker:

So you have to have the undertakers

Speaker:

coming in and get rid of the dead bodies

Speaker:

in the microenvironment.

Speaker:

And that's your immune system.

Speaker:

And they need glutamine as well.

Speaker:

So this is why you need to understand

Speaker:

evolutionary biology and biochemistry to

Speaker:

effectively manage cancer.

Speaker:

If you don't understand biology and

Speaker:

biochemistry and evolutionary biology,

Speaker:

you are still in the stone age when it

Speaker:

comes to this kind of stuff.

Speaker:

You're just peddling drugs and hoping for

Speaker:

the best case scenario.

Speaker:

Yes.

Speaker:

You don't know why things

Speaker:

are working or how they work.

Speaker:

We know exactly how things

Speaker:

are working and why they work.

Speaker:

And we try to perfect the system to keep

Speaker:

these tumor cells under

Speaker:

restricted fuel conditions.

Speaker:

And the body itself, when increased in

Speaker:

its health, will turn on the tumor cell,

Speaker:

on the tumor cells,

Speaker:

and use them for fuel.

Speaker:

It's called autolytic cannibalism.

Speaker:

So the body itself, when put under energy

Speaker:

restriction, every cell in the body must

Speaker:

earn its existence in that body.

Speaker:

There can be no weak, lame, inefficient

Speaker:

cells because the body will turn on them

Speaker:

and use them for fuel.

Speaker:

The tumor itself becomes a fuel source

Speaker:

for the rest of the body when you're put

Speaker:

into these states of nutritional ketosis.

Speaker:

So part of the solution to the problem is

Speaker:

when the normal cells recognize a

Speaker:

population of cells that are inefficient

Speaker:

in utilization of energy.

Speaker:

And they turn on them and dissolve them

Speaker:

and use them for fuel.

Speaker:

And people say, "I don't know what

Speaker:

happened to my tumor.

Speaker:

It just kind of disappeared when I was in

Speaker:

nutritional ketosis."

Speaker:

Well, you're damn body-ated.

Speaker:

Because it was inefficient.

Speaker:

They were using energy inefficiently.

Speaker:

And the body recognizes that.

Speaker:

And this is the term

Speaker:

autolytic cannibalism.

Speaker:

I published that.

Speaker:

But we also can strategically target

Speaker:

glutamine to work together.

Speaker:

It's a whole systems approach to

Speaker:

eliminating a bunch of cells that are

Speaker:

growing out of control, using energy very

Speaker:

inefficiently, being dependent

Speaker:

predominantly on glucose and glutamine,

Speaker:

and not being able to

Speaker:

burn fatty acids or ketones.

Speaker:

It's an elegant system.

Speaker:

It's so beautiful.

Speaker:

It works for the majority of people.

Speaker:

And nobody's doing this.

Speaker:

There's no clinical

Speaker:

trial anywhere on the planet.

Speaker:

Don't make much money out of it, can you?

Speaker:

Well, the money issue

Speaker:

now becomes another issue.

Speaker:

It's revenue first,

Speaker:

patient outcome second.

Speaker:

And I think people need to know that.

Speaker:

They should know that their disease is

Speaker:

supporting a giant industry.

Speaker:

Many people are grateful

Speaker:

for those who have cancer.

Speaker:

Because the cancer patient supports a

Speaker:

very lucrative process that would be

Speaker:

potentially disturbed if we were to find

Speaker:

a method or a way to prevent

Speaker:

or manage cancer effectively.

Speaker:

But man has made adjustments and

Speaker:

adaptations to disruptive technologies.

Speaker:

And they will do the same with this

Speaker:

cancer and chronic disease situation.

Speaker:

It's just a matter of time.

Speaker:

Because we cannot continue on this path

Speaker:

of this abysmal path that we've been on

Speaker:

for the last 75, 100 years.

Speaker:

So we will begin to change.

Speaker:

But there will be new industries and new

Speaker:

strategies for exploring

Speaker:

and keeping people healthy.

Speaker:

And others, so we're trying to get a

Speaker:

revenue transition of revenue generation

Speaker:

from one failed system to a system that

Speaker:

really works but has not yet been mature

Speaker:

to replace the revenue

Speaker:

lost from one system.

Speaker:

But I think that's all

Speaker:

part of the future as well.

Speaker:

But right now, my job is just to keep

Speaker:

people alive with a higher quality of

Speaker:

life, using the knowledge of the biology

Speaker:

and biochemistry of the

Speaker:

disease that we understand.

Speaker:

Yeah.

Speaker:

Now that's fascinating.

Speaker:

And I definitely would love to come back

Speaker:

to that in a minute.

Speaker:

I'd just like to quickly chat about the

Speaker:

ketogenic diet a bit more.

Speaker:

And I'm going to ask my question first

Speaker:

and then Ramblom from a group of mine.

Speaker:

I have a few concerns about sort of long

Speaker:

term utilization of the ketogenic diet,

Speaker:

not for everybody, but just I have found

Speaker:

that there are various people who do

Speaker:

follow a ketogenic diet, obviously are

Speaker:

going to run into certain problems, some

Speaker:

of them endocrine in nature, etc.

Speaker:

Now, I think of course, most people who

Speaker:

are going to explore this meta,

Speaker:

who are going to explore cancer treatment

Speaker:

from a metabolic standpoint, are going to

Speaker:

utilize a ketogenic diet as their first

Speaker:

step and why should they not?

Speaker:

Now, as I mentioned, I've

Speaker:

got a few sort of concerns.

Speaker:

For example, I believe there's rodent

Speaker:

data out there to show that ketogenic

Speaker:

diets long term may impair, I think it's

Speaker:

hepatic FGF21 signaling due to receptor

Speaker:

downregulation and that there are other

Speaker:

drivers issues there as well.

Speaker:

For example, peripheral insulin

Speaker:

resistance, which I'm sure you're

Speaker:

familiar with for the audience listening,

Speaker:

that being the idea that in some people

Speaker:

long term ketogenic diet,

Speaker:

adherence can essentially cause an

Speaker:

insulin resistant like state at the level

Speaker:

of the muscle because the body is sort of

Speaker:

not able or not readily utilizing the

Speaker:

glucose at its disposal effectively.

Speaker:

Now, I'm just some second here, but I

Speaker:

would be at least mechanistically

Speaker:

concerned that those high levels of

Speaker:

glucose might then also be a contributing

Speaker:

factor if you're sort of becoming more

Speaker:

and more insulin resistant.

Speaker:

So, the way I see it, just from the GKI

Speaker:

score side of things, and again, this is

Speaker:

just me piecing a few things together, so

Speaker:

tell me where I'm wrong, but are there

Speaker:

other ways that you can sort of look at

Speaker:

increasing your GKI score

Speaker:

maybe without necessarily

Speaker:

utilizing long term ketosis?

Speaker:

And I suppose that's

Speaker:

a question in itself.

Speaker:

Should we always be in a state of ketosis

Speaker:

or should we sort of keep it for a period

Speaker:

of time, such as when, hopefully not, you

Speaker:

have a disease like

Speaker:

this where it's needed?

Speaker:

But beyond that, what about strategies

Speaker:

where you are either intermittently

Speaker:

fasting and obviously including a certain

Speaker:

amount of carbohydrates

Speaker:

in that eating window?

Speaker:

Would that fasting period, obviously

Speaker:

again, the lower glycemic things, not

Speaker:

talking about swallowing large quantities

Speaker:

of honey and processed sugar,

Speaker:

and then, yeah, other fuel sources maybe

Speaker:

that can sort of increase ketone

Speaker:

production, your ketone

Speaker:

esters, your NCT oils,

Speaker:

yeah, again, I hope that makes sense.

Speaker:

I am rambling a bit and as you've no

Speaker:

doubt already figured out, I'm definitely

Speaker:

outside more with your house here.

Speaker:

But are there, do you have any concerns

Speaker:

again for the average person following a

Speaker:

ketogenic for a longer period of time,

Speaker:

perhaps in light of those

Speaker:

mechanisms that I mentioned?

Speaker:

And then beyond that, are those other

Speaker:

strategies aimed at sort of improving a

Speaker:

GKI index maybe without being in a

Speaker:

constant state of ketosis, are they worth

Speaker:

exploring or is it just not enough to

Speaker:

actually deal with the matter at hand?

Speaker:

Yeah, well, you got a lot of stuff that

Speaker:

you just threw at me right there.

Speaker:

Yeah, sorry about that.

Speaker:

But we can break it down.

Speaker:

But you're 100% correct.

Speaker:

There's a lot of people who use ketogenic

Speaker:

diets inappropriately that are not

Speaker:

balanced with micro and macro nutrients,

Speaker:

which then can lead to some of the

Speaker:

conditions that you mentioned in your

Speaker:

rambling.

Speaker:

Yeah, in your ramblings.

Speaker:

But I have seen the same thing.

Speaker:

I mean, when we fed

Speaker:

ketogenic diets to the mice,

Speaker:

or humans, in an unrestricted way, diets

Speaker:

that were not completely balanced in

Speaker:

micro and macro nutrients,

Speaker:

we got all of many of the health issues

Speaker:

that you mentioned were seen.

Speaker:

The tumors actually grew faster.

Speaker:

There was a complete

Speaker:

metabolic in homeostasis.

Speaker:

You found conditions that would be

Speaker:

reflective of some of

Speaker:

what you have mentioned.

Speaker:

That's why we try to get

Speaker:

away from the term diet.

Speaker:

And we talk about nutritional ketosis as

Speaker:

a state of metabolic homeostasis, where

Speaker:

your levels of ketones are not

Speaker:

exorbitantly high, and your levels of

Speaker:

glucose are not exorbitantly low.

Speaker:

But you are balanced in micro and macro

Speaker:

nutrients with a GKI of five or 10.

Speaker:

And exactly as you said, in our new paper

Speaker:

that we're working on right now, which

Speaker:

will revolutionize the treatment of

Speaker:

cancer and all these chronic diseases,

Speaker:

we have built a color-coded chart to

Speaker:

allow people to know what zones they're

Speaker:

in at any given time, and whether or not

Speaker:

they can move effectively

Speaker:

from one zone to the next.

Speaker:

Like, yes, intermittent fasting.

Speaker:

Or the enjoyment, if you have been in a

Speaker:

state of nutritional ketosis and you go

Speaker:

out and party, and your body then shows a

Speaker:

much higher GKI,

Speaker:

which would be unhealthy,

Speaker:

you would then know what you would need

Speaker:

to do to bring it back into a normal

Speaker:

range with the types of foods and

Speaker:

exercise is extremely important.

Speaker:

You can move these zones up and down.

Speaker:

So you don't have to feel compelled to be

Speaker:

locked into a particular state.

Speaker:

But having the knowledge of what are the

Speaker:

healthy states and what aren't the

Speaker:

healthy states, knowing, like for

Speaker:

example, the Greek patients that did

Speaker:

really well on the keto diet, it was a

Speaker:

calorie-restricted Mediterranean diet.

Speaker:

Sardines, salmon, avocados, olive oil,

Speaker:

and this kind of thing that most people

Speaker:

can do without too much difficulty.

Speaker:

They had good GKI.

Speaker:

They were very balanced in

Speaker:

micro and macro nutrients.

Speaker:

But you could switch

Speaker:

from that to a carnivore.

Speaker:

There's a lot of flexibility in what a

Speaker:

person can do to move in and out of these

Speaker:

health zones without

Speaker:

causing metabolic in-homeostasis.

Speaker:

So we're working on that.

Speaker:

We've published a big paper for the brain

Speaker:

cancer patients to tell them exactly and

Speaker:

address the questions that you raised.

Speaker:

What are the choices?

Speaker:

What are the variations that you can use

Speaker:

to maintain constant pressure on tumor

Speaker:

cells while constantly keeping the

Speaker:

homeostasis of your normal cells at the

Speaker:

highest level and metabolic homeostasis?

Speaker:

So we're working on that.

Speaker:

And to address your questions, most of

Speaker:

the health problems associated with

Speaker:

long-term ketogenic diets result from

Speaker:

micro and macro nutrient imbalances that

Speaker:

lead to pathologies, some of which you

Speaker:

have already elucidated.

Speaker:

So once the base of knowledge becomes

Speaker:

available for people,

Speaker:

they can then build diets.

Speaker:

And we call it nutritional ketosis,

Speaker:

because you can achieve that with a

Speaker:

carnivore diet, a

Speaker:

Mediterranean diet, a pescatarian diet.

Speaker:

Vegan diets are a little harder.

Speaker:

A veganism, you have to supplement with

Speaker:

micronutrients and some macronutrients in

Speaker:

order to maintain metabolic home.

Speaker:

It's not a natural situation.

Speaker:

Humans did not evolve as vegans.

Speaker:

If we were vegans, we would have been

Speaker:

extinct a long time ago.

Speaker:

But we are omnivores.

Speaker:

Our bodies were evolved to eat anything,

Speaker:

walks, crawls, flies,

Speaker:

or swims on this planet.

Speaker:

And you can build nutritional ketosis

Speaker:

from combinations of the natural foods

Speaker:

that we evolved to eat.

Speaker:

You just have to adjust the amounts that

Speaker:

you're eating and the

Speaker:

types that you're eating.

Speaker:

So in our new study that will come out

Speaker:

for managing cancer and chronic diseases,

Speaker:

deals exactly with what you have

Speaker:

mentioned, to allow people to always

Speaker:

remain in a state of maximal metabolic

Speaker:

homeostasis, but allowing the individual

Speaker:

to know what zone of health they're in to

Speaker:

allow mitochondria to be as healthy as

Speaker:

possible, and not too restrictive in

Speaker:

rigidity in what you're doing.

Speaker:

Because part of enjoyment of life is the enjoyment of what we

Speaker:

like to eat and drink.

Speaker:

And we don't like to be pigeonholed into

Speaker:

a particular way of doing something that

Speaker:

eventually turns someone

Speaker:

from being happy into miserable.

Speaker:

But now with our new system that will

Speaker:

come out on the apps, you will know at

Speaker:

any given time what you can eat, for how

Speaker:

long, and how healthy it can be.

Speaker:

So everybody will, and

Speaker:

everybody's unique individual.

Speaker:

We also have to recognize that we have

Speaker:

sex differences, we have age differences,

Speaker:

we have cultural differences, and we have

Speaker:

religious differences.

Speaker:

So people are in these cultural,

Speaker:

religion, different ages and things.

Speaker:

They have to build their diet and

Speaker:

lifestyle around a GKI that meets their

Speaker:

needs and keeps them

Speaker:

in a comfortable zone.

Speaker:

And they'll know the quantification of

Speaker:

that by looking at their glucose ketone

Speaker:

index and matching it to a

Speaker:

particular zone of health.

Speaker:

So we will eliminate adverse effects,

Speaker:

allowing people to be flexible so they

Speaker:

can prevent these kinds of situations.

Speaker:

And I think what we're running into now

Speaker:

is people say, "Oh, I'm doing a keto, I'm

Speaker:

eating lard every day, and I'm getting

Speaker:

unhealthy and I'm getting unhealthy."

Speaker:

Yeah, who wouldn't get unhealthy?

Speaker:

The question is, we want to eliminate

Speaker:

those kinds of ambiguities in what people

Speaker:

can and cannot eat and give them the

Speaker:

level of flexibility that will make it

Speaker:

comfortable for their existence while at

Speaker:

the same time

Speaker:

maintaining mitochondrial health.

Speaker:

And I think knowledge is power and every

Speaker:

individual will adjust their own GKI and

Speaker:

build their own diets and know how much

Speaker:

exercise they need to do and to keep

Speaker:

their body in a state of

Speaker:

nutritional and physical health.

Speaker:

So this is the future.

Speaker:

But we're aware of everything you said.

Speaker:

And when you start something off in the

Speaker:

beginning, people sometimes overdo it,

Speaker:

they do it the wrong way.

Speaker:

And then they end up with these

Speaker:

pathologies that become apparent for,

Speaker:

like you mentioned, with all these...

Speaker:

Our registry, sex, home industries.

Speaker:

Yeah, I mean, that

Speaker:

should not have to happen.

Speaker:

Paleolithic man never had

Speaker:

to deal with these things.

Speaker:

His main problem was starvation.

Speaker:

When you don't have any

Speaker:

food, you starve to death.

Speaker:

Well, you can only get ketones if you

Speaker:

have hormonal insulin levels.

Speaker:

Your ketones can never get ketoacidotic.

Speaker:

That's type 1 diabetes predominantly

Speaker:

where you have very high glucose and very

Speaker:

high ketones together in your body.

Speaker:

That's pathological.

Speaker:

Natural therapeutic ketosis is low

Speaker:

glucose elevated ketones, but not

Speaker:

elevated to the level of ketoacid because

Speaker:

you piss out excess ketones.

Speaker:

But when you don't have insulin, you keep

Speaker:

all that in your body.

Speaker:

Your body seems like a starving.

Speaker:

You can't get rid of the...

Speaker:

You're making ketones and too high of a

Speaker:

level, keeping too much in your body.

Speaker:

So again, and we also know that there are

Speaker:

some people that have carnitine

Speaker:

deficiencies that

Speaker:

can't metabolize ketones.

Speaker:

There are people that get severe rashes

Speaker:

from trying to get into these conditions.

Speaker:

And there's certain people take

Speaker:

medications that interfere with the

Speaker:

ability to metabolize ketone bodies.

Speaker:

So we have to be aware of the

Speaker:

interference of nutritional ketosis.

Speaker:

But at least when you're aware, you can

Speaker:

alert people to these hazards, metabolic

Speaker:

hazards, and they can

Speaker:

make adjustments themselves.

Speaker:

So all of this, we have

Speaker:

thought about all of this.

Speaker:

Why?

Speaker:

Because we don't do anything else in our

Speaker:

life except think about

Speaker:

these kinds of things.

Speaker:

We're laser focused.

Speaker:

We don't think about anything else except

Speaker:

what you just talked about.

Speaker:

Not just occasionally, 24 seven.

Speaker:

That's what we do.

Speaker:

Dr.

Speaker:

Seifried, thank you so much for that.

Speaker:

That was incredible.

Speaker:

To be honest, I think I've got through

Speaker:

what, 20% of the questions that I'd hoped

Speaker:

to be able to talk to you about today.

Speaker:

So I'm going to have to twist your arm

Speaker:

somehow, God willing, and to get me back

Speaker:

from at some point in the future.

Speaker:

What was your main

Speaker:

question that I did not answer?

Speaker:

Oh, no.

Speaker:

I wanted to go down the rabbit hole

Speaker:

regarding various fatty acids and

Speaker:

specifically talk about saturated fats

Speaker:

versus unsaturated fats and the issues

Speaker:

regarding some people running into

Speaker:

insulin resistance, having sort of high

Speaker:

amounts of saturated

Speaker:

fats in the ceramides.

Speaker:

I don't know if you've

Speaker:

seen that to be an issue.

Speaker:

We published a big paper looking at all

Speaker:

that stuff in mice,

Speaker:

unrestricted and unrestricted.

Speaker:

It's hard to get into ketosis on

Speaker:

polyunsaturated fatty acids,

Speaker:

but they're, the omega three fatty acids

Speaker:

are very healthy for people.

Speaker:

Some of the omega sixes are not.

Speaker:

So we published a big paper on all this.

Speaker:

So almost everything I have looked at in

Speaker:

one way or the other, I just don't have

Speaker:

time to talk about it at all, but our

Speaker:

open access papers on restricted and

Speaker:

unrestricted diets, high carb keto and

Speaker:

fish oil diets and

Speaker:

all this kind of stuff.

Speaker:

So we have looked at that and the body is

Speaker:

a machine that

Speaker:

metabolizes the fuels effectively.

Speaker:

Ketones will be

Speaker:

produced from saturated fat.

Speaker:

MCT oil, little MCT oil, is really great

Speaker:

in producing ketone bodies endogenously.

Speaker:

D beta hydroxybutyrate rather than L's.

Speaker:

There's a way to do all that.

Speaker:

We've looked at almost

Speaker:

every damn thing we can look at.

Speaker:

So I have papers on that, but yes, we

Speaker:

have looked at that.

Speaker:

We try to do everything, always remember,

Speaker:

everything is metabolized majority in the

Speaker:

mitochondria, the cytoplasm.

Speaker:

So once you understand these metabolic

Speaker:

pathways, you know how to keep your

Speaker:

mitochondria as healthy as possible,

Speaker:

which will make you, because ultimately

Speaker:

you're interested in

Speaker:

avoiding chronic disease.

Speaker:

That's it.

Speaker:

You don't want chronic disease.

Speaker:

You don't want cancer.

Speaker:

You don't want chronic disease.

Speaker:

How do you prevent that?

Speaker:

Keep your mitochondria healthy.

Speaker:

How do you keep your

Speaker:

mitochondria healthy?

Speaker:

Keep glucose down and

Speaker:

elevate ketones, the mitochondria.

Speaker:

And I don't have time to talk, but in our

Speaker:

new paper, we talk about the

Speaker:

bioenergetics of burning fatty acids,

Speaker:

ketone bodies, and pyruvate.

Speaker:

The bioenergetic related to the delta G

Speaker:

prime ATP hydrolysis.

Speaker:

And how we can get

Speaker:

more bang for your buck.

Speaker:

Every breath of air can give you more ATP

Speaker:

when you're burning ketone body than when

Speaker:

you're burning pyruvate or fatty acids.

Speaker:

So we know the bioenergetics.

Speaker:

We published that.

Speaker:

And our big paper is going

Speaker:

to be coming out on that.

Speaker:

And we got all that from the late Richard

Speaker:

Veach, one of the great, and he was Hans

Speaker:

Krebs' last graduate student.

Speaker:

So he and I would talk for hours and

Speaker:

hours and hours about all the

Speaker:

bioenergetics of mitochondria and what

Speaker:

you need to keep it

Speaker:

healthy and functional.

Speaker:

So there's a strong bioenergetic

Speaker:

explanation for a lot of what I'm saying.

Speaker:

And that's in our papers.

Speaker:

We'll definitely be sure to

Speaker:

link them in all the show.

Speaker:

Yeah.

Speaker:

Make sure, yeah.

Speaker:

Tell folks that all of

Speaker:

our papers are open access.

Speaker:

So anybody with a

Speaker:

computer can get the information.

Speaker:

Now people are going to be overwhelmed

Speaker:

and say, oh my God,

Speaker:

Seifree published so many papers.

Speaker:

Yeah.

Speaker:

Well, a lot of it's on

Speaker:

what I'm talking about.

Speaker:

A lot of it's on other things.

Speaker:

But you can go through and

Speaker:

ferret out what we're doing.

Speaker:

And people need to know that all of our

Speaker:

research is supported by philanthropy and

Speaker:

private foundations.

Speaker:

So when we keep people

Speaker:

alive who are stage four cancer,

Speaker:

they so-called terminal.

Speaker:

And all of a sudden you're living a lot

Speaker:

longer with a higher quality of life.

Speaker:

Some people feel very compelled to donate

Speaker:

to our research because they

Speaker:

want to.

Speaker:

And one thing I want to make sure, never

Speaker:

say we have a cure for cancer.

Speaker:

Because I have no clue whether what we do

Speaker:

will cure cancer or not.

Speaker:

The only thing that we have seen over and

Speaker:

over again is we have a longer

Speaker:

progression-free survival without

Speaker:

symptoms and a very increased overall

Speaker:

survival of cancer patients.

Speaker:

Whether they're cured

Speaker:

or not, we don't know.

Speaker:

But I consider success in keeping people

Speaker:

given terminal diagnosis alive far, far

Speaker:

longer than what the establishment

Speaker:

predicted their lifespan to be.

Speaker:

So I never like to use the term terminal

Speaker:

because I have a lot of people that I

Speaker:

know who are still alive.

Speaker:

I don't know.

Speaker:

Sometime in the future they may be

Speaker:

terminal, but they're not dead yet and

Speaker:

they're pretty healthy.

Speaker:

So what the hell does that mean?

Speaker:

And they were told they only had nine

Speaker:

months to live and

Speaker:

they're around six years.

Speaker:

Who made the mistake there?

Speaker:

Why was someone told they have six months

Speaker:

or a year to live and they're living five

Speaker:

and six years or even longer?

Speaker:

How did anybody make

Speaker:

that level of mistake?

Speaker:

They made the mistake because they don't

Speaker:

understand metabolic therapy and how long

Speaker:

you can possibly live with

Speaker:

a higher quality of life.

Speaker:

But whether you get a

Speaker:

cure or not, I have no clue.

Speaker:

All we know is we have a new strategy for

Speaker:

managing cancer and chronic disease that

Speaker:

is far more powerful and successful than

Speaker:

anything out there right now.

Speaker:

The problem is people just don't know

Speaker:

about it and don't know

Speaker:

how to implement it yet.

Speaker:

And that's going to take

Speaker:

that will be the future.

Speaker:

That will be down to people like us,

Speaker:

aiming to educate the greater public.

Speaker:

Dr.

Speaker:

Seifried, thank you

Speaker:

so much for your time.

Speaker:

For people who are interested in your

Speaker:

work and to learn more about your various

Speaker:

metabolic therapies,

Speaker:

where can we point them to?

Speaker:

Well again, I have my metabolic papers

Speaker:

already published, open access.

Speaker:

And donations go to Travis

Speaker:

Christofferson's Foundation

Speaker:

for Cancer Metabolic Therapy.

Speaker:

It's a legitimate foundation.

Speaker:

And the university, Boston College

Speaker:

itself, the biology department for sure.

Speaker:

So that keeps us going and we've got a

Speaker:

couple of blockbuster things coming out

Speaker:

that are really going to transform the

Speaker:

healthcare industry dramatically.

Speaker:

And they'll be out within the year.

Speaker:

And then you're going to see

Speaker:

organizations set up around these

Speaker:

approaches for metabolic health.

Speaker:

And we're going to bring a lot of people

Speaker:

back into what we call normalcy,

Speaker:

metabolic homeostasis, if they want to.

Speaker:

I'm not twisting anybody's arm here.

Speaker:

It's only if people who want to, if they

Speaker:

want to live in a toxic

Speaker:

state, that's their choice.

Speaker:

But we have a tool now to allow them to

Speaker:

come out of those toxic states and live a

Speaker:

healthy, productive life with a clear

Speaker:

quantitative assessment to do that.

Speaker:

And that is coming down and you'll see

Speaker:

that within the next

Speaker:

year or two, for sure.

Speaker:

So we're very hopeful for

Speaker:

managing chronic diseases.

Speaker:

And I think most people are going to be

Speaker:

very appreciative as they begin to

Speaker:

benefit from what we're doing.

Speaker:

No, I'm sure they're well.

Speaker:

I mean, ultimately, I think most disease,

Speaker:

the way I'm starting to view it, it

Speaker:

ultimately comes down to sort of removing

Speaker:

the environmental burden or whatever

Speaker:

environmental trigger there is as driving

Speaker:

the disease, improving the metabolic

Speaker:

health and subsequent treatment,

Speaker:

mitochondrial health, and then dealing

Speaker:

with the stress component, which is also

Speaker:

obviously overlooked.

Speaker:

And I think when you get those three sort

Speaker:

of components sort of dialed in, you sort

Speaker:

of solve 90% of the equation, at least

Speaker:

when it comes to chronic disease.

Speaker:

Which is mostly

Speaker:

crippling Western societies.

Speaker:

Yes.

Speaker:

So it's the single most biggest problem.

Speaker:

Cancer and chronic diseases are dementia,

Speaker:

type 2 diabetes, obesity,

Speaker:

cardiovascular disease, cancer.

Speaker:

You can go right down the list.

Speaker:

It's just like everything.

Speaker:

So what do we do with all these healthy

Speaker:

people if they will...

Speaker:

We're keeping a lot of people alive,

Speaker:

working for a longer period of time with

Speaker:

a high quality of life.

Speaker:

I mean, you're going to have to have a

Speaker:

readjustment of society.

Speaker:

Yeah.

Speaker:

Well, let's aim to get there and then we

Speaker:

can do what that problem arises.

Speaker:

Yes, absolutely.

Speaker:

All right.

Speaker:

Well, listen, thank you very much.

Speaker:

Thank you, Dr.

Speaker:

Seifried.

Speaker:

It's been an absolute honor and I

Speaker:

appreciate your time.

Speaker:

Yeah.

Speaker:

Well, thank you. I'll